Veterinary Product Information
Vet > Recombitek C6/CV (Canada)
The information provided typically includes the following:
20000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
Recombitek C6/CV (Canada)
This page contains information on Recombitek C6/CV for veterinary use.The information provided typically includes the following:
- Recombitek C6/CV Indications
- Warnings and cautions for Recombitek C6/CV
- Direction and dosage information for Recombitek C6/CV
Recombitek C6/cv
This treatment applies to the following species:Manufacturer: Merial
MERIAL CANADA INC.Canine Distemper-adenovirus Type 2-coronavirus-parainfluenza-parvovirus Vaccine
Modified Live Virus, Canarypox Vector, Leptospira Bacterin
Description
Recombitek® C6/CV contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, parvovirus, and coronavirus; and a liquid suspension of Leptospira canicola and L. icterohaemorrhagiae. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible dogs.Recombitek C6/CV Indications
Recombitek® C6/CV is recommended for the vaccination of healthy dogs 6 weeks of age and older for prevention of disease due to canine distemper virus, canine parvovirus, canine coronavirus, canine adenovirus type 1 (canine hepatitis), canine adenovirus type 2 (canine respiratory disease complex), canine parainfluenza virus, and the bacteria L. canicola and L. icterohaemorrhagiae.Dosage
Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1 mL dose 2 to 3 weeks later. Dogs younger than 12 weeks of age should be revaccinated with a single 1 mL dose every 2 to 3 weeks, the last dose given at or over 12 weeks of age. Revaccinate annually with a single 1 mL dose.Precautions
Store at 2-7°C (35-45°F). Do not freeze. Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn container and all unused contents. Contains gentamicin as a preservative. It is generally recommended to avoid vaccination of pregnant dogs. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Transient lethargy, as well as pain and swelling at the site of injection, may occur following use of this product. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian.SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
RECOMBITEK is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
1-888-Merial-1 (1-888-637-4251)
Distributed In Canada By MERIAL CANADA, INC., Baie d'Urfé, Qc, H9X 3V1, Canada
|
Contains |
|
Prod. No. |
|
|
25 Doses |
25 x 1 Dose, Lyophilized 25 x 1 Dose (1 mL), Liquid |
2262-25 |
RM555R8 |
Nac No.
1182060220000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
| Telephone: | 514-457-1555 | |
| Order Desk: | 888-637-4251 (888-MERIAL1) | |
| Fax: | 514-457-1175 | |
| Website: | www.merial.com | |
| Email: | service.canada@merial.com |
![]() |
Every effort has been made to ensure the accuracy of the Recombitek C6/CV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Recombitek C6/CV product label or package insert. |
![]() |
Printable Version | ![]() |
Email Page |








